2022 – 2026
Title:
Effectiveness and implementation of a digital intervention for pediatric chronic pain co-designed with patients (Digital SPA) (PID2021-122885OA-I00)
Funding Agency:
Spanish Ministry of Science and Innovation
Chief research:
Rocío de la Vega
Aims:
There is currently no patient-centered digital intervention designed for the self-management of pediatric chronic pain in Spanish or that has been culturally-adapted to Spain, and that is co-designed by patients so the aim of this project is to co-develop and evaluate the effectiveness and implementation of a a digital intervention for children with Chronic Pain (Digital SPA). The results of this study will allow for the publication of four scientific papers and to offer an evidence-based digital co-created solution for pediatric chronic pain. It would allow for dissemination to Spanish-speaking countries. A roadmap on achieving successful implementation will be provided.
2020 – 2023
Title:
Variables predictoras del abuso de opioides prescritos en los pacientes con dolor crónico no oncológico. (Vapreabopi) (UMA20-FEDERJA-118)
Funding Agency:
Proyectos de I+D+i en el marco del Programa Operativo FEDER- PROYECTO DE I+D RETOS DE LA SOCIEDAD ANDALUZA
Chief researchers:
Carmen Ramírez Maestre
Alicia E. López-Martínez
2020 – 2024
Title:
Predictive variables of prescription opioid abuse in patients with chronic non-oncologic pain: Development of a risk detection scale (PID2019-106086RB-I00)
Funding Agency:
Ministerio de Ciencia, Innovación e Universidades
Chief researchers:
Carmen Ramírez Maestre
Alicia E. López-Martínez
Aims:
The aim of this project is to provide medical professionals with an instrument to detect the risk of opioid abuse in patients with chronic non-oncologic pain. To this end, two studies will be conducted, each with a different primary objective. The objective of the first study will be to evaluate a theoretical model of opioid drug abuse that includes the key variables that have been identified in previous research as predictors of adherence to appropriate opioid treatment use in patients with chronic non-oncologic pain who are receiving opioids. The primary objective of the second study is to design and evaluate the validity of a brief instrument that will include those aspects demonstrated to be most relevant in predicting the abuse of prescription opioids in the first study. The instrument will be designed for rapid and easy administration to facilitate its use in health centers. Accurate and early detection and classification of patients who are at greatest risk of opioid abuse will allow alternative medications to be considered, and will also help to determine the level of monitoring that will be needed based on the risk group to which the patient has been classified, should the physician decide that treatment with opioids is indicated.
